| Dr Kristina R Liaugaudas, MD | |
|
15800 95th Ave N, Maple Grove, MN 55369-4400 | |
| (952) 993-1440 | |
| Not Available |
| Full Name | Dr Kristina R Liaugaudas |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 15800 95th Ave N, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114902434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 47036 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Park Nicollet Methodist Hospital | Saint louis park, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novacare Outpatient Rehabilitation East Inc | 3678480290 | 617 |
| Park Nicollet Clinic | 7911819438 | 1529 |
News Archive
Axis Surgical Technologies, Inc., reports the first evaluation of the C-MOR™ Visualization Device in a spine procedure. The C-MOR™ is a self-contained portable direct-imaging tool that functions much like a standard arthroscopic tower, yet at a fraction of both the size and cost. The handheld lightweight device offers practitioners the convenience of intraoperative visualization and complete operability in one hand. The C-MOR™ comprises a distinctive and cost-effective imaging device offering benefits to medical practitioners in a variety of applications, including lengthy surgeries requiring constant re-evaluation of the operating field over the course of the surgery.
An MRI (Magnetic Resonance Image) diagnostic clinic is an unlikely place to expect a warm, fuzzy, friendly staff. Having an MRI is serious business, often related to traumatic or orthopedic injuries, brain diseases or dental TMJ problems.
When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
Two studies at Sam Houston State University examined issues of sexual orientation and intimate partner violence, including its impact on substance abuse and physical and mental health as well as the effects of child abuse on its victims.
› Verified 4 days ago
| Entity Name | Park Nicollet Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Axis Surgical Technologies, Inc., reports the first evaluation of the C-MOR™ Visualization Device in a spine procedure. The C-MOR™ is a self-contained portable direct-imaging tool that functions much like a standard arthroscopic tower, yet at a fraction of both the size and cost. The handheld lightweight device offers practitioners the convenience of intraoperative visualization and complete operability in one hand. The C-MOR™ comprises a distinctive and cost-effective imaging device offering benefits to medical practitioners in a variety of applications, including lengthy surgeries requiring constant re-evaluation of the operating field over the course of the surgery.
An MRI (Magnetic Resonance Image) diagnostic clinic is an unlikely place to expect a warm, fuzzy, friendly staff. Having an MRI is serious business, often related to traumatic or orthopedic injuries, brain diseases or dental TMJ problems.
When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
Two studies at Sam Houston State University examined issues of sexual orientation and intimate partner violence, including its impact on substance abuse and physical and mental health as well as the effects of child abuse on its victims.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristina R Liaugaudas, MD 3800 Park Nicollet Blvd, Credentialing, St Louis Park, MN 55416-2527 Ph: () - | Dr Kristina R Liaugaudas, MD 15800 95th Ave N, Maple Grove, MN 55369-4400 Ph: (952) 993-1440 |
News Archive
Axis Surgical Technologies, Inc., reports the first evaluation of the C-MOR™ Visualization Device in a spine procedure. The C-MOR™ is a self-contained portable direct-imaging tool that functions much like a standard arthroscopic tower, yet at a fraction of both the size and cost. The handheld lightweight device offers practitioners the convenience of intraoperative visualization and complete operability in one hand. The C-MOR™ comprises a distinctive and cost-effective imaging device offering benefits to medical practitioners in a variety of applications, including lengthy surgeries requiring constant re-evaluation of the operating field over the course of the surgery.
An MRI (Magnetic Resonance Image) diagnostic clinic is an unlikely place to expect a warm, fuzzy, friendly staff. Having an MRI is serious business, often related to traumatic or orthopedic injuries, brain diseases or dental TMJ problems.
When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
Two studies at Sam Houston State University examined issues of sexual orientation and intimate partner violence, including its impact on substance abuse and physical and mental health as well as the effects of child abuse on its victims.
› Verified 4 days ago
Dr. Karin Soby Gilkison, M.D./M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10150 Niagra Lane N #210, Maple Grove, MN 55369 Phone: 612-871-1145 | |
Katti Lauren Woerner, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14500 99th Ave N, Medical Specialty Clinic, Maple Grove, MN 55369 Phone: 763-898-1000 Fax: 763-898-1323 | |
Asim Said Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Daniel Keeley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9555 Upland Ln N, Maple Grove, MN 55369 Phone: 952-993-1440 | |
Dr. Viet Pham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9875 Hospital Dr, Maple Grove, MN 55369 Phone: 763-581-1000 | |
Aazim Kamal Omer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14500 99th Ave N, Maple Grove, MN 55369 Phone: 763-898-1000 |